CNTB Connect Biopharma Holdings Limited
Healthcare$2.40+2.13%ClosedMarket Cap: $135.7M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.12
P/S
2767.19
EV/EBITDA
-3.33
DCF Value
$0.65
FCF Yield
-18.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-60312.5%
Net Margin
-58350.0%
ROE
-49.4%
ROA
-49.9%
ROIC
-67.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 null | $0.00 | NaN% | $-15.5M | $-15.1M | $— | — |
| FY null | $64.0K | 100.0% | $-58.1M | $-55.5M | $— | — |
| Q2 null | $48.0K | 100.0% | $-13.4M | $-12.9M | $— | — |
| Q4 null | $698.0K | 100.0% | $-9.6M | $-8.9M | $— | — |
| FY null | $26.0M | 100.0% | $-22.5M | $-15.6M | $— | — |
| Q2 null | $24.1M | 100.0% | $13.6M | $14.8M | $— | — |
| Q4 null | $0.00 | NaN% | $-37.0M | $-31.6M | $— | — |
| FY null | $0.00 | NaN% | $-69.1M | $-62.1M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-34.8M | $-30.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-54.3M | $-56.7M | $— | — |
| FY null | $0.00 | NaN% | $-119.3M | $-118.1M | $— | — |
| Q2 null | $0.00 | NaN% | $-60.0M | $-59.9M | $— | — |